629
Articles
17.1K
Citations
2
avg. Impact Factor
60
h-index

Most Cited Articles of Department of Urology in 2013

TitleJournalYearCitations
EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstructionEuropean Urology2013808
The mechanism of action of phosphodiesterase type 5 inhibitors in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasiaEuropean Urology2013103
Flexible-dose fesoterodine in elderly adults with overactive bladder: results of the randomized, double-blind, placebo-controlled study of fesoterodine in an aging population trialJournal of the American Geriatrics Society201381
Systematic review of combination drug therapy for non-neurogenic male lower urinary tract symptomsEuropean Urology201367
Hsa-mir-124-3 CpG island methylation is associated with advanced tumours and disease recurrence of patients with clear cell renal cell carcinomaBritish Journal of Cancer201365
Efficacy and safety of tadalafil 5 mg once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: subgroup analyses of pooled data from 4 multinational, randomized, placebo-controlled clinical studiesUrology201347
Minimally invasive percutaneous nephrolithotomy: an alternative to retrograde intrarenal surgery and shockwave lithotripsyWorld Journal of Urology201343
Tadalafil once daily improves ejaculatory function, erectile function, and sexual satisfaction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and erectile dysfunction: results from a randomized, placebo- and tamsulosin-controlled, 12-week double-blind studyJournal of Sexual Medicine201341
Laparoendoscopic single-site partial nephrectomy: a multi-institutional outcome analysisEuropean Urology201333
Avanafil for the treatment of erectile dysfunction: initial data and clinical key propertiesTherapeutic Advances in Urology201332
Galectin-3 expression in prostate cancer and benign prostate tissues: correlation with biochemical recurrenceWorld Journal of Urology201330
High CRP values predict poor survival in patients with penile cancerBMC Cancer201329
Review on ultrasound measurement of bladder or detrusor wall thickness in women: techniques, diagnostic utility, and use in clinical trialsWorld Journal of Urology201326
Serum C-reactive protein: a prognostic factor in metastatic urothelial cancer of the bladderMedical Oncology201325
Perspectives on treatment of metastatic castration-resistant prostate cancerOncologist201324
Preoperative serum C- reactive protein: a prognostic marker in patients with upper urinary tract urothelial carcinomaBMC Cancer201322
The role of phosphodiesterases in bladder pathophysiologyNature Reviews Urology201322
Tumour shrinkage measured with first treatment evaluation under VEGF-targeted therapy as prognostic marker in metastatic renal cell carcinoma (mRCC)British Journal of Cancer201322
Apoptosis gene polymorphisms and risk of prostate cancer: a hospital-based study of German patients treated with brachytherapyUrologic Oncology: Seminars and Original Investigations201321
Phosphodiesterase inhibitors in clinical urologyExpert Review of Clinical Pharmacology201320
Elevated C-reactive protein values predict nodal metastasis in patients with penile cancerBMC Urology201320
Does overweight influence the prognosis of renal cell carcinoma? Results of a multicenter studyInternational Journal of Urology201319
The use of a single daily dose of tadalafil to treat signs and symptoms of benign prostatic hyperplasia and erectile dysfunctionResearch and Reports in Urology201315
Laparoendoscopic single-site nephroureterectomy for upper urinary tract urothelial carcinoma: outcomes of an international multi-institutional study of 101 patientsBJU International201314
PDE5-Is for the Treatment of Concomitant ED and LUTS/BPHCurrent Bladder Dysfunction Reports201312